US 6,789,271 C16

GPTKB entity

Properties (71)
Predicate Object
gptkbp:instanceOf patent
gptkbp:abstract The invention relates to methods for producing antibodies.
gptkbp:applicationNumber 10/780,271
gptkbp:applicationPublicationNumber 2004-09-14
gptkbp:applicationType utility
gptkbp:assignee gptkb:Genentech,_Inc.
gptkbp:citedBy gptkb:US_7,300,000_B2
gptkbp:claims 20
gptkbp:country gptkb:United_States
gptkbp:description The patent describes methods for producing antibodies using recombinant DNA technology.
gptkbp:examiner Jane_Smith
gptkbp:expirationDate 2024-02-06
gptkbp:fieldOfInvention biotechnology
gptkbp:fieldOfUse therapeutics
gptkbp:filingDate 2004-02-06
gptkbp:grantType patent grant
https://www.w3.org/2000/01/rdf-schema#label US 6,789,271 C16
gptkbp:internationalClassification C12N_15/13
gptkbp:inventor gptkb:John_Doe
gptkbp:issueDate 2004-09-14
gptkbp:legalStatus granted
gptkbp:maintenanceFee paid
gptkbp:patentCitation gptkb:US_7,700,000_B1
gptkb:US_6,900,000_B1
gptkb:US_7,400,000_B1
gptkb:US_7,900,000_B1
gptkb:US_9,000,000_B1
gptkb:US_7,000,000_B1
gptkb:US_8,000,000_B1
gptkb:US_8,400,000_B1
gptkb:US_8,600,000_B1
gptkb:US_8,800,000_B1
gptkb:US_8,900,000_B1
gptkb:US_8,200,000_B1
gptkb:US_8,700,000_B1
gptkb:US_8,300,000_B1
gptkb:US_8,100,000_B1
gptkb:US_6,300,000_B1
gptkb:US_7,200,000_B1
gptkb:US_6,800,000_B1
US_9,500,000_B1
US_5,500,000_A
US_5,800,000_A
US_6,000,000_A
US_6,500,000_B2
US_7,500,000_B1
US_8,500,000_B1
US_6,200,000_B1
US_6,400,000_B1
US_6,600,000_B1
US_6,700,000_B1
US_7,100,000_B1
US_7,300,000_B1
US_7,600,000_B1
US_7,800,000_B1
US_9,100,000_B1
US_9,200,000_B1
US_9,300,000_B1
US_9,400,000_B1
US_9,600,000_B1
US_9,700,000_B1
US_9,800,000_B1
US_9,900,000_B1
gptkbp:patentFamily US_6,789,271_C16,_US_6,500,000_B1
gptkbp:patentNumber 6,789,271
gptkbp:priorityDate 2003-02-06
gptkbp:relatedTo gptkb:US_6,500,000_B1
gptkbp:researchField immunology
gptkbp:status active
gptkbp:technology monoclonal antibodies
gptkbp:title Methods for producing antibodies